Pedestrians walk past the Bombay Stock Exchange (BSE) building in Mumbai, on 9 March 2020 | Photo: Dhiraj Singh | Bloomberg
Text Size:

Mumbai: The outperformance of India’s midcap stocks over their larger peers since the coronavirus pandemic engulfed global markets may take a breather, according to some investors.

Fund managers at Star Health & Allied Insurance Co. and Smartsun Capital Pte said they are currently avoiding midcaps based on global economic cues and valuations. Both said there is more safety in buying large stocks now that India has become the epicenter of virus resurgence in Asia, while inflation is set to rise in the U.S. and China as the world’s two biggest economies are rebounding.

The S&P BSE Midcap Index has outperformed the benchmark S&P BSE Sensex Index in all but five months since the end of 2019, according to data compiled by Bloomberg. The smaller stock measure has gained nearly 33% in that span, more than double the rise in the broader benchmark, with the outperformance becoming particularly pronounced amid the recent market chill.

While the Sensex is now flirting with a technical correction after climbing to a record high in February, expensive smaller stocks may have more to lose, the fund managers said.

“Midcap euphoria has picked up and people are now operating in a casino,” said Aneesh Srivastava, chief investment officer at Star Health, which overseas about $694 million in India assets. His firm has started nibbling at shares of some large companies and plans “meaningful buying” on corrections, especially in bank stocks.

The easy monetary policies of global central banks have lifted midcaps more than large stocks as they were relatively very cheap, but that’s not the situation anymore, Srivastava said. He also sees larger companies as better equipped to navigate crises and opportunities, and therefore to win market share from smaller rivals, once vaccinations curtail the spread of infections.

The Indian midcap gauge is trading at 21.3 times 12-month forward earnings estimates while the Sensex is at about 20 times, according to data compiled by Bloomberg.

Sumeet Rohra, a fund manager at Smartsun Capital, said “there is more margin of safety in larger names now on valuation, while a continuation of the selloff can evaporate liquidity from smaller names at a very fast pace.”

Large stocks in pharmaceuticals and technology are “a great place to hide now, not midcaps,” he said. — Bloomberg

Also read: India’s sizzling stock market rally seen continuing next year as banks, financials take lead


Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism